NCI & Northeastern University Improving Tumor-Targeting Nanoparticles
PEG coated nanoparticleshave been shown to remain in the tumors and bloodstream longer compared to gelatin nanoparticles.
Mansoor Amiji, Ph.D., who heads the National Cancer Institute’s (NCI) Cancer Nanotechnology Platform Partnership at Northeastern University, and graduate student Sushma Kommareddy conducted the research on the nanoparticles. By adding a thin coating of the biocompatible polymer PEG to the surface of nanoparticles, the nanoparticles have been shown to remain in the tumors and bloodstream longer compared to gelatin nanoparticles. This discovery could lead to more effective nanoparticles with tumor-targeting properties.
Dr. Amiji will serve as Symposium Chair for CancerNano 2007: Nanotechnology for Cancer Prevention, Diagnosis and Treatment at the 10th annual Nanotech 2007, the world’s largest technical conference and trade show. CancerNano 2007 will feature distinguished speakers from MIT, Massachusetts General Hospital, Northeastern University, Georgetown University, and many more. For more details on the CancerNano 2007 Symposium, please visit: http://www.nsti.org/Nanotech2007/symposia/Cancer_Diagnostics_Imaging_Treatment.html
